Delays in discharge in a tertiary care pediatric hospital

Rajendu Srivastava1, Bryan L Stone, Raza Patel

  • 1Division of Inpatient Medicine, Department of Pediatrics, University of Utah Health Sciences Center, Salt Lake City, Utah 84113, USA. raj.srivastava@hsc.utah.edu

Insights

Hospital discharge delays impact care efficiency and costs. Nearly a quarter of patients experienced delays, contributing to extended length of stay (LOS) and significant financial costs.

Area of Science:

  • Pediatric hospital medicine
  • Healthcare quality improvement
  • Health services research

Background:

  • Delays in hospital discharges negatively affect patient care efficiency and timeliness.
  • Discharge delays are a critical indicator of inpatient care quality.

Purpose of the Study:

  • To quantify the number, duration, and types of delays in hospital discharges.
  • To assess the impact of these delays on overall length of stay (LOS) and associated costs.

Main Methods:

  • A prospective observational cohort study was conducted at a tertiary-care children's hospital.
  • Data were collected from 171 children across two medical teams over one month.
  • The Delay Tool was used to classify delays, with LOS and costs extracted from administrative data.

Main Results:

  • 22.8% of patients experienced at least one delay, contributing to 82 extra hospital days (9% of total) and $170,000 in costs (8.9% of total).
  • The primary causes of delays were physician behavior (42.3%), discharge planning (21.8%), consultations (14.1%), and test scheduling (12.8%).
  • Mean LOS was 7.3 days and mean costs were $15,197.

Conclusions:

  • A significant proportion of pediatric patients could have been discharged earlier, highlighting substantial impacts on LOS and healthcare expenditures.
  • Interventions should focus on standardizing physician discharge criteria, optimizing discharge planning processes, and improving the timeliness of consultations and diagnostic testing.
Abstract

Related Concept Videos

Tertiary Healthcare System01:21

Tertiary Healthcare System

Specialized care provided over an extended period is called tertiary care. Usually, a primary or secondary care physician will refer a patient to tertiary care. A patient's maximum physical and mental function is restored in tertiary care, which is caused due to the impact of a chronic illness or condition. Tertiary care aims to achieve the highest level of functioning possible while managing chronic illness. For example, a patient who falls and fractures their hip will need secondary care to...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Discharge Summary Forms01:31

Discharge Summary Forms

The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...